Telomere length | COPD | ||
---|---|---|---|
N | cOR (95% CI) | aOR (95% CI)a | |
Male + Femaleb | 455 |  |  |
 Q4 | 82 | 1.00 | 1.00 |
 Q3 | 95 | 1.03 (0.72–1.45) | 0.95 (0.66–1.36) |
 Q2 | 116 | 1.55 (1.19–2.01) | 1.35 (0.99–1.86) |
 Q1 | 162 | 2.14 (1.67–2.74) | 1.68 (1.19–2.37) |
P for trend |  |  < 0.01 | < 0.01 |
 Male | 171 |  |  |
 Q4 | 27 | 1.00 | 1.00 |
 Q3 | 30 | 0.97 (0.48–1.95) | 0.90 (0.45–1.81) |
 Q2 | 45 | 1.37 (0.87–2.16) | 1.28 (0.77–2.14) |
 Q1 | 69 | 2.11 (1.41–3.15) | 1.72 (0.98–3.00) |
P for trend |  | < 0.01 | 0.04 |
Female | 284 | Â | Â |
 Q4 | 55 | 1.00 | 1.00 |
 Q3 | 65 | 1.04 (0.69–1.57) | 0.95 (0.62–1.45) |
 Q2 | 71 | 1.69 (1.20–2.38) | 1.41 (0.95–2.12) |
 Q1 | 93 | 2.21 (1.55–3.14) | 1.64 (1.07–2.51) |
P for trend |  |  < 0.01 | < 0.01 |